机器人辅助食管切除术与电视辅助胸腔镜食管切除术(REVATE):一项随机对照试验的研究方案
REVATE 为多中心、开放标签随机对照试验,纳入拟行左喉返神经旁淋巴结清扫的食管鳞状细胞癌患者,随机分配至机器人辅助食管切除术或电视辅助胸腔镜食管切除术。主要结局为左喉返神经旁淋巴结清扫失败率,定义为病理报告未见可识别淋巴结或术后出现永久性(持续>6个月)左喉返神经麻痹。
要点
- 纳入拟行左喉返神经旁淋巴结清扫的食管鳞状细胞癌患者,随机分至机器人辅助或胸腔镜食管切除术。
- 主要结局为左喉返神经旁淋巴结清扫失败率,失败定义为病理报告无可识别淋巴结或永久性左喉返神经麻痹。
- 次要结局包括成功切除的喉返神经旁淋巴结数、术后恢复、住院时长、30天和90天死亡率、生活质量及肿瘤学结局。
核心结论
- REVATE 研究旨在探索机器人辅助食管切除术是否较电视辅助胸腔镜食管切除术更有利于完成左喉返神经旁淋巴结清扫。
研究设计与样本
- 多中心、开放标签、随机对照试验,纳入拟行左喉返神经旁淋巴结清扫的食管鳞状细胞癌患者,随机分配至机器人辅助食管切除术组或电视辅助胸腔镜食管切除术组。
主要发现
- 主要结局为左喉返神经旁淋巴结清扫失败率,失败定义为病理报告未见可识别淋巴结或术后出现永久性(持续>6个月)左喉返神经麻痹。
- 次要结局包括成功切除的喉返神经旁淋巴结数、术后恢复、住院时长、30天和90天死亡率、生活质量及肿瘤学结局。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Radical lymph node dissection (LND) along the left recurrent laryngeal nerve (RLN) is surgically demanding and can be associated with substantial postoperative morbidity. The question of whether robot-assisted esophagectomy (RE) might be superior to video-assisted thoracoscopic esophagectomy (VATE) for performing LND along the RLN in patients with esophageal squamous cell carcinoma (ESCC) remains open. METHODS/DESIGN: We will conduct a multicenter, open-label, randomized controlled trial (Robotic-assisted Esophagectomy vs Video-Assisted Thoracoscopic Esophagectomy (REVATE)) enrolling patients with ESCC scheduled to undergo LND along the RLN. Patients will be randomly assigned to either RE or VATE. The primary outcome measure will be the rate of unsuccessful LND along the left RLN, which will be defined as: failure to remove lymph nodes along the left RLN (i.e., no identifiable nodes on pathology reports); or occurrence of permanent (duration > 6 months) left RLN palsy following LND. Secondary outcomes will include the number of successfully removed RLN nodes, postoperative recovery, length of hospital stay, 30-day and 90-day mortality, quality of life, and oncological outcomes. DISCUSSION: The REVATE study provides an opportunity to explore whether RE could facilitate LND along the left RLN-a complex surgical procedure that, as of now and with the use of VATE, remains difficult to perform and associated with a significant burden of morbidity. TRIAL REGISTRATION: ClinicalTrials.gov, NCT03713749 . Registered on 22 October 2018.
引用
- Chao YK, Li ZG, Wen YW, et al. Robotic-assisted Esophagectomy vs Video-Assisted Thoracoscopic Esophagectomy (REVATE): study protocol for a randomized controlled trial. Trials. 2019. PMID: 31182150. doi:10.1186/s13063-019-3441-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。